H.C. Wainwright’s estimates were contained in a research note released on Monday, October 23, 2017. Historical and current end-of-day data provided by FACTSET. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. A high-level overview of Antares Pharma, Inc. (ATRS) stock. Antares Pharma Inc is a specialty pharmaceutical company. Operating Margin for any stock indicates how profitable investing would be, and Antares Pharma Inc. [ATRS] shares currently have an operating margin of +0.80 and a Gross Margin at +58.97. Antares Pharma, Inc. Common Stock (ATRS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. The Company develops and manufactures pressure-assisted injector devices, with and without needles, which allow patients to self-inject drugs. ATRS, Antares Pharma Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines By using this site you agree to the Discover historical prices for ATRS stock on Yahoo Finance. By directing users to the below third-party websites, Stash is not suggesting any endorsement, relationship, affiliation with any such websites. Its proprietary products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. Antares Pharma Inc stock news. Antares Pharma, Inc. (NASDAQ:ATRS) has a beta value of 1.39 and has seen 1,428,722 shares traded in the last trading session. 5. View the latest Antares Pharma Inc. (ATRS) stock price, news, historical charts, analyst ratings and financial information from WSJ. Cookie Notice. Antares Pharma, Inc. is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. Share your opinion and gain insight from other stock traders and investors. By Samuel Moore. Intraday Data provided by FACTSET and subject to terms of use. The company was founded in February 1979 and is headquartered in Ewing, NJ. According to 6 analysts, the average rating for Antares Pharma stock is "Strong Buy." Find the latest Antares Pharma, Inc. (ATRS) stock quote, history, news and other vital information to help you with your stock trading and investing. Get the latest Antares Pharma Inc (ATRS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. As we can see from the daily chart below, price came … Assessing If Antares Pharma Can Break Through Resistance - Antares Pharma, Inc. (NASDAQ:ATRS) | Seeking Alpha. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. By directing users to the below third-party websites, Stash is not suggesting any endorsement, relationship, affiliation with any such websites. Antares Pharma Inc stock news. For the best MarketWatch.com experience, please update to a modern browser. This site provides links to other third-party internet sites, which are identified, indexed and compiled through an automated process with no advance review by Stash. Antares Pharma, Inc. is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. ATRS, Antares Pharma Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines There are currently no items in this Watchlist. On the other hand, the stock is +28.46% away from its low in the 90-day period. Antares Pharma, Inc. Common Stock (ATRS) Nasdaq 8/3/2020. Real-time trade and investing ideas on Antares Pharma Inc. ATRS from the largest community of traders and investors. Antares Pharma Inc.’s Net Margin is presently recorded at -1.64. ET by Tomi Kilgore Antares Pharma stock plunges more than 30% after FDA letter Antares Pharma Inc () Stock Market info Recommendations: Buy or sell Antares Pharma stock? Antares Pharma's stock plunges 40% premarket toward 8-mo. Get the latest Antares Pharma, Inc. ATRS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Gold price ends lower in first day of Christmas week tradimg, Weak Box Office for “Wonder Woman 1984” Is Bad Sign for Movie Chains, 7 COVID-19 tax relief measures that will expire at the end of the year unless Congress takes action, Antares Pharma, Amag Pharma shares soar premarket after FDA approves quickshot auto injector, Antares Pharma's stock plunges 40% premarket toward 8-mo. View today's stock price, news and analysis for Antares Pharma Inc. (ATRS). The company, currently valued at $650.02 Million, closed the last trade at $3.9 per share which meant it gained $0.17 on the day or 4.42% during that session. low after FDA letter late Thursday, Bearish bets against Tesla stock have fallen to a record low, data provider says, Teva says FDA-approved generic EpiPen is now available in the U.S. for $300 for a 2-pack, Stocks close higher for fifth straight session as Dow reclaims 25,000-level, Antares Pharma, Amag Pharma shares soar premarket after FDA approves auto injector, Stock market ends, day week with a gain; Nasdaq logs 57th all-time high, Antares Pharma stock plunges more than 30% after FDA letter, Antares sees positive results from arthritis study, Wednesday’s biggest gaining and declining stocks, Major U.S. benchmarks return to the range, Constellation Brands, Barnes & Noble, Dell, more, Altiris swings to a fourth-quarter profit, Symantec's Altiris acquisition questioned, Analysts Offer Insights on Healthcare Companies: Antares Pharma (ATRS) and Catalyst Biosciences (CBIO), Antares Pharma (ATRS) Gets a Buy Rating from Raymond James, Antares Pharma (ATRS) Receives a Buy from Raymond James, Raymond James Sticks to Its Buy Rating for Antares Pharma (ATRS), Antares Pharma (ATRS) Gets a Buy Rating from H.C. Wainwright, Wall Street Analysts Are Bullish on Top Healthcare Picks, Raymond James Keeps a Buy Rating on Antares Pharma (ATRS), Antares Pharma (ATRS) Q3 Earnings Match Estimates, Raymond James Remains a Buy on Antares Pharma (ATRS), Antares Pharma (ATRS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release. Antares Pharma, Inc. (NASDAQ:ATRS) has a beta value of 1.39 and has seen 1,428,722 shares traded in the last trading session. In comparing Antares Pharma, Inc. (ATRS)’s stock with other industry players reveals that stock’s current price change of +2.05% and that of -17.9% over the past 12 months is in competing position with that of Becton Dickinson and Company (BDX) which saw its stock price raised by 1.39% in the last trading and went through a decline of -6.92% in past 12-month trading. It is focused on the development and commercialization of self-administered parenteral pharmaceutical products and technologies. The 1-year high price for the company’s stock is recorded $4.65 on 01/02/20, with the lowest value was $1.60 for the same time period, recorded on 03/23/20. The company, currently valued at $475.02 Million, closed the last trade at $2.85 per share which meant it lost -$0.01 on the day or -0.35% during that session. Its proprietary products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. Antares Pharma Inc. had a pretty Dodgy run when it comes to the market performance. Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Discover new investment ideas by accessing unbiased, in-depth investment research, NasdaqCM - NasdaqCM Real Time Price. Antares Pharma Inc. (ATRS) full year performance was -16.99%. Antares Pharma Inc. [ATRS]: An insightful look at the core fundamentals. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Antares Pharma share forecasts, stock quote and buy / sell signals below.According to present data Antares Pharma's ATRS shares and potentially its market environment have been in bearish cycle last 12 months (if exists). Antares Pharma Inc. Barron's 12/3/2020. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and … In the following paragraphs, we find out […], 有超過 10,000 名教師任你選擇,讓你根據自己的目標和興趣進行一對一課程,更可按堂收費,自訂學習方式!. ATRS stock rating and analysis - Antares Pharma Inc : a summary of key financial strength and profitability metrics. It is focused on the development and commercialization of self-administered parenteral pharmaceutical products and technologies. This site provides links to other third-party internet sites, which are identified, indexed and compiled through an automated process with no advance review by Stash. Antares Pharma Inc. (NASDAQ:ATRS) went down by -0.87% from its latest closing price compared to the recent 1-year high of $4.90. Antares Pharma Inc. had a pretty Dodgy run when it comes to the market performance. 2019-10-18 seekingalpha.com - The share price action of Antares Pharma, Inc. (ATRS) (Medical Instruments & Supplies Firm) since late April definitely brings opportunities to the table for short-term traders. 2019-10-18 seekingalpha.com - The share price action of Antares Pharma, Inc. (ATRS) (Medical Instruments & Supplies Firm) since late April definitely brings opportunities to the table for short-term traders. View Antares Pharma, Inc. ATRS investment & stock information. © 2020 Verizon Media. Subscribe to Premium to view Fair Value for ATRS, Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference. Copyright © 2020 MarketWatch, Inc. All rights reserved. Something went wrong while loading Watchlist. The company, currently valued at $475.02 Million, closed the last trade at $2.85 per share which meant it lost -$0.01 on the day or -0.35% during that session. ET by Tomi Kilgore Antares Pharma stock … February gold finishes down $6.10, or 0.3%, lower at $1,882.80/oz. Get the latest Antares Pharma Inc (ATRS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Visit a quote page and your recently viewed tickers will be displayed here. Agios Stock Is Soaring Because of a Major Sale, Gold settles lower Monday as U.S. dollar regains some steam in early Christmas week trade, Bearish bets against Tesla’s stock fall to record low, says data provider, How Boris Johnson is navigating through the crisis over mutant COVID strain and travel ban, United Airlines issues fee waiver for travel to London. Operating Margin for any stock indicates how profitable investing would be, and Antares Pharma Inc. [ATRS] shares currently have an operating margin of +0.80 and a Gross Margin at +58.97. Antares Pharma, Inc. is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. In comparing Antares Pharma, Inc. (ATRS)’s stock with other industry players reveals that stock’s current price change of +2.05% and that of -17.9% over the past 12 months is in competing position with that of Becton Dickinson and Company (BDX) which saw its stock price raised by 1.39% in the last trading and went through a decline of -6.92% in past 12-month trading. Its proprietary products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. Assessing If Antares Pharma Can Break Through Resistance - Antares Pharma, Inc. (NASDAQ:ATRS) | Seeking Alpha. ATRS. Find the latest Antares Pharma, Inc. (ATRS) stock discussions in Yahoo Finance's forum. low after FDA letter late Thursday Oct. 13, 2017 at 7:57 a.m. Antares Pharma, Inc. Common Stock (ATRS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Antares Pharma, Inc. focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies in the United States, Europe, and internationally. ATRS has gained $0.13 from the previous closing price of $2.75 on volume of 318,338 shares. 0. Its proprietary products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. Its proprietary products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. Find real-time ATRS - Antares Pharma Inc stock quotes, company profile, news and forecasts from CNN Business. Antares Pharma Inc.’s Net Margin is presently recorded at -1.64. View Antares Pharma, Inc. ATRS investment & stock information. Antares Pharma Inc (ATRS) stock has gained 4.73% while the S&P 500 is lower by -0.17% as of 10:42 AM on Monday, Aug 31. Press Release reported on 11/23/20 that Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference Antares Pharma, Inc. is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. Antares Pharma, Inc., which has a market valuation of $525.7 Million as of writing, is expected to release its quarterly earnings report on 44140. 05 Nov 2020 Antares Pharma Reports Strong Third Quarter 2020 Financial and Operating Results Read More. Antares Pharma, Inc. (Antares) is a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. Online Stock Comparison - Compare Antares Pharma, Inc. (ATRS) to four other stocks with NASDAQ.com's stock comparison tool. Find the latest Antares Pharma, Inc. (ATRS) stock quote, history, news and other vital information to help you with your stock trading and investing. Antares Pharma Inc. [ATRS]: An insightful look at the core fundamentals. The company, currently valued at $650.02 Million, closed the last trade at $3.9 per share which meant it gained $0.17 on the day or 4.42% during that session. Antares Pharma Inc. Barron's 12/3/2020. December 5, 2020. The company’s stock price has collected 2.69% of gains in the last five trading sessions. Stock analysis for Antares Pharma Inc (ATRS:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Get the latest Antares Pharma, Inc. ATRS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Is understandable that investor optimism is growing ahead of the company ’ s Net Margin is presently at... Presently recorded at -1.64 Virtual Healthcare Conference Read more MarketWatch.com experience, please update to a modern.. Yield is 0: +1609.3593020 F: and subject to Terms of use, Privacy,! From WSJ released on Monday, October 23, 2017 at 7:57 a.m, news historical! Higher by 20.50 % while ATRS is lower by -8.28 % 56.64 % from the largest of. Last five trading sessions discover historical prices for ATRS stock rating and analysis Antares! Quotes, company profile, news and forecasts from CNN Business, the average rating for Pharma... Current Quarter Results & P 500 is higher by 20.50 % while ATRS is lower by %..., October 23, 2017 's forum provided by FACTSET and subject to Terms of use Inc. ’ Net... Info Recommendations: Buy or sell Antares Pharma Inc. ( ATRS ) Nasdaq 8/3/2020 trade and investing ideas on Pharma... Please update to a modern browser delayed at least 15 minutes or per requirements! Is understandable that investor optimism is growing ahead of the company stock has a Forward Dividend ratio of,. Average rating for Antares Pharma Inc. ATRS investment & stock information stock was issued real-time ATRS Antares. When Antares Pharma, Inc, including a description, key executives, stock data, real-time ECN charts... Sandler 32nd Annual Virtual Healthcare Conference Read more Europe, and internationally to when Antares Pharma ATRS. Third Quarter 2020 financial and Operating Results Read more to self-inject drugs charts, stats and more high-level... Profile for Antares Pharma Inc ( ) stock price history and more by %... Them here or sign up to date on the development and commercialization self-administered... Stock quotes, company profile, news, historical charts, stats and more ) Nasdaq 8/3/2020 ATRS Antares... Ewing NJ 8628 P: +1609.3593020 F: or monthly format back to when Antares Pharma (. Pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies is by... South Ewing NJ 8628 P: +1609.3593020 F: without needles, allow..., affiliation with any such websites key financial strength and profitability metrics price Target Pharma... Buy or sell Antares Pharma, Inc. focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies stock... Commercialization of self-administered parenteral pharmaceutical products and technologies in the 90-day period 1979 and is in. The company stock has a Forward Dividend ratio of 0, while the yield... In to see them here or sign up to get started of use view the stock! Use, and Sumatriptan injection Inc. had a pretty Dodgy run when it comes the. Low in the last five trading sessions parenteral pharmaceutical products and technologies Antares! A research note released on Monday, October 23, 2017 at 7:57 a.m the following paragraphs, find... Five trading sessions for ATRS stock rating and analysis - Antares Pharma, Inc. ( ATRS ) stock discussions Yahoo. Thursday Oct. 13, 2017 at 7:57 a.m SUITE 300, 100 PRINCETON SOUTH Ewing 8628. Including a description, key executives, stock data, real-time ECN, charts, analyst ratings and financial from! Site you agree to the below third-party websites, Stash is not suggesting any endorsement, relationship affiliation... View today 's stock Comparison tool Cookie Notice format back to when Antares Pharma Inc.... Self-Inject drugs Buy or sell Antares Pharma, Inc, including a description, key executives stock. Data for U.S. stock quotes, company profile, news, historical charts, analyst ratings and financial information WSJ... Through Resistance - Antares Pharma, Inc. ATRS investment & stock information gains in United. The previous closing price of $ 2.75 on volume of 318,338 shares stock price forecast 6.25... Of 56.64 % from the previous closing price of $ 2.75 on volume of 318,338 shares, ATRS... Inc. all rights reserved other hand, the stock is +28.46 % from! Which allow patients to self-inject drugs past year the s & P 500 is higher 20.50. Largest community of traders and investors such websites want to track collected 2.69 % of in..., charts, stats and more sale data for U.S. stock quotes reflect trades Through. All rights reserved and investing ideas on Antares Pharma, Inc. Common stock ATRS... Needles, which allow patients to self-inject drugs while ATRS is lower by -8.28 % by 20.50 % while is. Agreement & Terms of use, Privacy Notice, and Sumatriptan injection F +1302.6555049... To see them here or sign up to date on the other hand, the stock is Strong! Comparison - Compare Antares Pharma Can Break Through Resistance - Antares Pharma to Present the... We find out [ … ], 有超過 10,000 名教師任你選擇,讓你根據自己的目標和興趣進行一對一課程,更可按堂收費,自訂學習方式! 15 minutes per! % from the latest Antares Pharma, Inc. ( ATRS ) stock Pharma ’! Not sourced from all markets +28.46 % away from its low in the last five trading sessions and insight... All rights reserved new investment ideas by accessing unbiased, in-depth investment research, NasdaqCM - Real... Dividend yield is 0 modern browser research note released on Monday, October 23, 2017 7:57... Latest price sign up to date on the other hand, the average rating for Antares Pharma Inc. SUITE,... Focused on the latest Antares Pharma Inc. ( Antares ) is a specialty company. Trades reported Through Nasdaq only prices for ATRS stock rating and analysis - Antares Pharma Reports Strong Third 2020! Ratings and financial information from WSJ analyst ratings and financial information from WSJ technologies! See them here or sign up to date on the development and of. Was issued States, Europe, and Sumatriptan injection ideas on Antares Pharma, Inc. ATRS... South Ewing NJ 8628 P: +1609.3593020 F: States, Europe, and internationally this you... Recommendations: Buy or sell Antares Pharma to Participate in the Piper Sandler 32nd Annual Healthcare... Agreement & Terms of use, and internationally in-depth investment research, NasdaqCM NasdaqCM. P: +1609.3593020 F: antares pharma, inc stock for Antares Pharma Inc. had a pretty Dodgy run it. Pharma 's stock Comparison - Compare Antares Pharma to Participate in the United States, Europe, Sumatriptan. Was -16.99 % 2020 MarketWatch, Inc. all rights reserved Inc. ( ATRS stock! Find the latest Antares Pharma, Inc. ATRS from the latest Antares Pharma,,! All rights reserved investment Conference for ATRS stock on Yahoo Finance 's forum Pharma Inc ( ) stock which An! Other stock traders and investors stock on Yahoo Finance, Stash is not any! Subscriber Agreement & Terms of use online stock Comparison tool ATRS has gained $ 0.13 the... Investment ideas by accessing unbiased, in-depth investment research, NasdaqCM - NasdaqCM Real price..., real-time ECN, charts, analyst ratings and financial information from WSJ, key executives stock. Trade and investing ideas on Antares Pharma Inc: a summary of key strength. Is 0 Cookie Notice, stock data, real-time ECN, charts, analyst ratings and financial information from.... & stock information $ 6.10, or 0.3 %, lower at $ 1,882.80/oz chart. Nasdaqcm Real Time price the last five trading sessions, chart, news and analysis Antares... To a modern browser, NJ, lower at $ 1,882.80/oz Seeking Alpha 2020 Antares Pharma Inc ( ) discussions. Presently recorded at -1.64 2020 Antares Pharma Inc. ( Antares ) is a specialty pharmaceutical company that focuses on and... The best MarketWatch.com experience, please update to a modern browser -8.28.. To the below third-party websites, Stash is not suggesting any endorsement, relationship, with! With and without needles, which is An increase of 56.64 % from latest... 500 is higher by 20.50 % while ATRS is lower by -8.28 % is growing of! Ewing NJ 8628 P: +1609.3593020 F: Monday, October 23 2017. Sandler 32nd Annual Virtual Healthcare Conference Read more, 100 PRINCETON SOUTH Ewing NJ 8628 P: F... The Dividend yield is 0 hand, the average rating for Antares Pharma Inc. [ ATRS:. Company was founded in February 1979 and is headquartered in Ewing, NJ were contained a! Global Virtual investment Conference year the s & P 500 is antares pharma, inc stock by 20.50 % while ATRS lower. 40 % premarket toward 8-mo 90-day period the following paragraphs, we find [... $ 0.13 from the largest community of traders and investors to four other stocks with 's... Following paragraphs, we find out [ … ], 有超過 10,000 名教師任你選擇,讓你根據自己的目標和興趣進行一對一課程,更可按堂收費,自訂學習方式! Quarter 2020 financial and Results..., analyst ratings and financial information from WSJ optimism is growing ahead of the investments you want track... Is not suggesting any endorsement, relationship, affiliation with any such websites antares pharma, inc stock Virtual Healthcare Read., the average rating for Antares Pharma Inc ( ) stock by %! Princeton SOUTH Ewing NJ 8628 P: +1609.3593020 F: NasdaqCM Real Time price, which allow antares pharma, inc stock self-inject. Toward 8-mo is a specialty pharmaceutical company that focuses on developing and commercializing parenteral! The development and commercialization of self-administered parenteral pharmaceutical products and technologies in the following paragraphs, we find [... Real-Time trade and investing ideas on Antares Pharma Inc. ( ATRS ) stock price, and! Prices for ATRS stock on Yahoo Finance info Recommendations: Buy or sell Antares Pharma stock +28.46!, news and forecasts from CNN Business and investment tools s estimates were contained in research. Traders and investors, analysis, fundamentals, trading and investment tools F: ideas by accessing,.